Latest (77) Full Text Articles (1570) Focus on GERD Article Summary

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: A phase IIb trial
Gastroenterology, 01/24/2014  Clinical Article

Zeuzem S, et al. – The authors performed a phase IIb, randomized, double–blind, placebo–controlled trial to evaluate the efficacy and safety of the combination of simeprevir, peginterferon–α2a (PegIFN), and ribavirin (RBV) in patients with hepatitis C virus (HCV) genotype–1 infection previously treated with PegIFN and RBV. In treatment–experienced patients, 12, 24, or 48 weeks simeprevir (100 mg or 150 mg once daily) in combination with 48 weeks PegIFN and RBV significantly increased rates of SVR at 24 weeks compared with patients given placebo, PegIFN, and RBV and was generally well tolerated.

Methods

  • The authors analyzed data from patients who did not respond (null response), had a partial response, or relapsed after treatment with PegIFN and RBV, randomly assigned to receive simeprevir (100 or 150 mg, once daily) for 12, 24, or 48 weeks plus PegIFN and RBV for 48 weeks (n = 396), or placebo plus PegIFN and RBV for 48 weeks (n = 66).
  • All patients were followed for 24 weeks after planned end of treatment; the primary end point was the proportion of patients with sustained virologic response (SVR; undetectable HCV RNA) at that time point.

Results

  • Overall, rates of SVR at 24 weeks were significantly higher in the groups given simeprevir than those given placebo (61%-80% vs 23%; P < .001), regardless of prior response to PegIFN and RBV (simeprevir vs placebo: prior null response, 38%-59% vs 19%; prior partial response, 48%-86% vs 9%; prior relapse, 77%-89% vs 37%).
  • All groups had comparable numbers of adverse events; these led to discontinuation of simeprevir or placebo and/or PegIFN and RBV in 8.8% of patients given simeprevir and 4.5% of those given placebo.

► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from PDR - powered by MDLinx

Most Popular Gastroenterology Articles

Last month's top read Top Articles of 2014

1 Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms Neurogastroenterology & Motility, February 25, 2014    Clinical Article
Exclusive Author Commentary

2 Use of antibiotics in patients with Crohn's disease: A systematic review and meta-analysis Journal of Digestive Diseases, December 4, 2014    Evidence Based Medicine    Review Article

3 Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double-blind placebo-controlled trial Neurogastroenterology & Motility, February 10, 2014    Clinical Article

4 Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia Digestive Diseases and Sciences, December 12, 2014    Clinical Article

5 Variation in treatment of patients with inflammatory bowel diseases at major US referral centers Clinical Gastroenterology and Hepatology , December 1, 2014    Clinical Article

6 Vedolizumab: a review of its use in adult patients with moderately to severely active ulcerative colitis or Crohn’s disease BioDrugs, December 11, 2014    Review Article

7 Diet and inflammatory bowel disease: review of patient-targeted recommendations Clinical Gastroenterology and Hepatology , October 10, 2014    Review Article

8 Accuracy of rapid fecal calprotectin test in monitoring inflammatory bowel diseases under treatment with TNFα antagonists Digestive Diseases and Sciences, December 9, 2014    Clinical Article

9 Long-term outcome of patients with Crohn’s disease who discontinued infliximab therapy upon clinical remission Clinical Gastroenterology and Hepatology , December 5, 2014    Clinical Article

10 The results of seton drainage combined with anti-TNF therapy for anal fistula in Crohn's disease Colorectal Disease, December 3, 2014    Clinical Article

11 Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: A meta-analysis of controlled trials Digestive and Liver Diseases, December 8, 2014    Clinical Article

12 The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence following surgery for Crohn's disease Clinical Gastroenterology and Hepatology , November 7, 2014    Clinical Article

13 Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease Full Text Clinical and Experimental Gastroenterology, December 15, 2014    Free full text    Review Article

14 The home environment and childhood obesity in low-income households: indirect effects via sleep duration and screen time Full Text BMC Public Health, November 26, 2014    Free full text    Clinical Article

15 Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterology & Motility, December 3, 2014    Review Article

16 Why, when and how to de-escalate therapy in inflammatory bowel diseases Alimentary Pharmacology and Therapeutics, July 2, 2014    Review Article

17 Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the help randomized clinical trial JAMA Internal Medicine, October 13, 2014    Evidence Based Medicine    Clinical Article

18 Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease Gastroenterology, April 2, 2014    Clinical Article

19 Effectiveness of adalimumab in perianal fistulas in Crohn’s disease patients naive to anti-TNF therapy Journal of Clinical Gastroenterology, December 10, 2014    Clinical Article

20 Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity International Journal of Obesity, November 14, 2014    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Other Topics in Gastroenterology

Register now to view all our site's content (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from our site and our sponsors
View Samples and Register